These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 37953576)

  • 41. Topical Application of 0.5% Timolol Maleate Hydrogel for the Treatment of Superficial Infantile Hemangioma.
    Wu HW; Liu C; Wang X; Zhang L; Yuan W; Zheng JW; Su LX; Fan XD
    Front Oncol; 2017; 7():137. PubMed ID: 28702374
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Outpatient use of oral propranolol and topical timolol for infantile hemangiomas: survey results and comparison with propranolol consensus statement guidelines.
    Kumar MG; Coughlin C; Bayliss SJ
    Pediatr Dermatol; 2015; 32(2):171-9. PubMed ID: 25556828
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Combined Oral and Topical Beta Blockers for the Treatment of Early Proliferative Superficial Periocular Infantile Capillary Hemangioma.
    Marey HM; Elmazar HF; Mandour SS; Khairy HA
    J Pediatr Ophthalmol Strabismus; 2018 Jan; 55(1):37-42. PubMed ID: 28991344
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Topical ophthalmic solution in infantile hemangioma.
    Jha AK; Mallik SK; Raihan M
    J Postgrad Med; 2012; 58(2):163-5. PubMed ID: 22718070
    [No Abstract]   [Full Text] [Related]  

  • 45. Topical timolol 0.5% gel-forming solution for small deep facial infantile hemangiomas.
    Sorrell J; Chamlin SL
    Pediatr Dermatol; 2013; 30(5):592-4. PubMed ID: 23889228
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Propranolol Targets Hemangioma Stem Cells via cAMP and Mitogen-Activated Protein Kinase Regulation.
    Munabi NC; England RW; Edwards AK; Kitajewski AA; Tan QK; Weinstein A; Kung JE; Wilcox M; Kitajewski JK; Shawber CJ; Wu JK
    Stem Cells Transl Med; 2016 Jan; 5(1):45-55. PubMed ID: 26574555
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Topical timolol as adjunct therapy to shorten oral propranolol therapy for infantile hemangiomas.
    Mannschreck DB; Huang AH; Lie E; Psoter K; Puttgen K
    Pediatr Dermatol; 2019 May; 36(3):283-289. PubMed ID: 30968438
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Successful treatment of ulcerated infantile hemangioma with brimonidine-timolol cream: 2 cases report and review of the literature.
    Almebayadh M
    J Dermatolog Treat; 2020 Jun; 31(4):433-434. PubMed ID: 30973791
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Efficacy of low-dose
    Zhu HJ; Liu Q; Deng XL; Guan YX
    Exp Ther Med; 2015 Sep; 10(3):1013-1018. PubMed ID: 26622431
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Treatment of small superficial haemangioma with timolol 0.5% ophthalmic solution: a series of 20 cases.
    Oranje AP; Janmohamed SR; Madern GC; de Laat PC
    Dermatology; 2011; 223(4):330-4. PubMed ID: 22179543
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Safety and efficacy of topical timolol treatment of infantile haemangioma: a prospective trial.
    Borok J; Gangar P; Admani S; Proudfoot J; Friedlander SF
    Br J Dermatol; 2018 Jan; 178(1):e51-e52. PubMed ID: 28771668
    [No Abstract]   [Full Text] [Related]  

  • 52. Three-month evaluation of dorzolamide hydrochloride/timolol maleate fixed-combination eye drops versus the separate use of both drugs.
    Inoue K; Shiokawa M; Sugahara M; Wakakura M; Soeda S; Tomita G
    Jpn J Ophthalmol; 2012 Nov; 56(6):559-63. PubMed ID: 23001284
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Treatment of Children Hemangiomas.
    Ţarcă E
    Chirurgia (Bucur); 2020; 115(5):643-649. PubMed ID: 33138909
    [No Abstract]   [Full Text] [Related]  

  • 54. Phace syndrome: is timolol gel a chance for treatment?
    Fontana E; Causin F; De Corti F; Belloni Fortina A
    J Eur Acad Dermatol Venereol; 2017 Jul; 31(7):e345-e346. PubMed ID: 28129480
    [No Abstract]   [Full Text] [Related]  

  • 55. Using Topical Citric Acid to Treat an Infected Ulcerated Hemangioma in an Infant: A Case Study.
    Nagoba B; Davane M; Warad B; Jamadar N; Gavkare AM
    Wounds; 2021 Feb; 33(2):E17-E19. PubMed ID: 33914691
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Childhood haemangiomas treated with 1% timolol maleate cream].
    Kramer D; Cossio ML; Downey C
    Rev Chil Pediatr; 2016; 87(1):69-70. PubMed ID: 26455702
    [No Abstract]   [Full Text] [Related]  

  • 57. Comparison of the efficacy between topical timolol and pulsed dye laser in the treatment of ulcerated infantile haemangiomas: a randomized controlled study.
    Chen QY; Chang L; Qiu YJ; Ying HR; Chang SJ; Zhang Y; Chen ZA; Ma G; Lin XX
    J Eur Acad Dermatol Venereol; 2021 Apr; 35(4):e303-e305. PubMed ID: 33289216
    [No Abstract]   [Full Text] [Related]  

  • 58. Physicochemical stability of a new topical timolol 0.5% gel formulation for the treatment of infant hemangioma.
    Merino-Bohórquez V; Casas M; Caracuel F; Cameán M; Fernández-Anguita MJ; Ramírez-Soto G; Lucero MJ
    Pharm Dev Technol; 2015; 20(5):562-9. PubMed ID: 25047057
    [TBL] [Abstract][Full Text] [Related]  

  • 59. An infant with localized vasoconstriction following topical propranolol exposure for infantile hemangioma.
    Saerens J; Gutermuth J; Janmohamed SR
    Pediatr Dermatol; 2021 Jan; 38(1):263-264. PubMed ID: 33275306
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Topical timolol maleate for treatment of tufted angioma.
    Zhang B; Zhang N; Wei L; Li L; Qiu L; Ma L
    J Dermatol; 2019 Nov; 46(11):e402-e403. PubMed ID: 31245858
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.